Literature DB >> 15574420

A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation.

Alexandra Montagner1, Armelle Yart, Marie Dance, Bertrand Perret, Jean-Pierre Salles, Patrick Raynal.   

Abstract

SHP2 was recently found to down-regulate PI3K activation by dephosphorylating Gab1 but the mechanisms explaining the positive role of the Gab1/SHP2 pathway in EGF-induced Ras activation remain ill defined. Substrate trapping experiments now suggest that SHP2 dephosphorylates other Gab1 phosphotyrosines located within a central region displaying four YXXP motifs. Because these sites are potential docking motifs for Ras-GAP, we tested whether SHP2 dephosphorylates them to facilitate Ras activation. We observed that a Gab1 construct preventing SHP2 recruitment promoted membrane relocation of RasGAP. Moreover, a RasGAP-inactive mutant restored the activation of Ras in cells transfected with SHP2-inactivating Gab1 mutant or in SHP2-deficient fibroblasts, supporting the hypothesis that RasGAP is a downstream target of SHP2. To determine whether Gab1 is a RasGAP-binding partner, a Gab1 mutant deleted of four YXXP motifs was produced. The deletion suppressed RasGAP redistribution and restored the defective Ras activation caused by SHP2-inactivating mutations. Moreover, Gab1 was found to interact with RasGAP SH2 domains, only under conditions where SHP2 is not activated. To identify Ras-GAP-binding sites, Tyr to Phe mutants of Gab1 YXXP motifs were produced. Gab1 constructs mutated on Tyr(317) were severely affected in RasGAP binding and were the most active in compensating for Ras-defective activation and blocking RasGAP redistribution induced by SHP2 inactivation. We have thus localized on Gab1 a Ras-negative regulatory tyrosine phosphorylation site involved in RasGAP binding and showed that an important SHP2 function is to down-regulate its phosphorylation to disengage RasGAP and sustain Ras activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574420     DOI: 10.1074/jbc.M410012200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's disease.

Authors:  Xiao-Ling Pan; Ru-Jing Ren; Gang Wang; Hui-Dong Tang; Sheng-Di Chen
Journal:  Neurosci Bull       Date:  2010-06       Impact factor: 5.203

Review 2.  Targeting protein tyrosine phosphatases for anticancer drug discovery.

Authors:  Latanya M Scott; Harshani R Lawrence; Saïd M Sebti; Nicholas J Lawrence; Jie Wu
Journal:  Curr Pharm Des       Date:  2010-06       Impact factor: 3.116

3.  Antagonism or synergism. Role of tyrosine phosphatases SHP-1 and SHP-2 in growth factor signaling.

Authors:  Ning Wang; Zhe Li; Ronghua Ding; Gerald D Frank; Takaaki Senbonmatsu; Erwin J Landon; Tadashi Inagami; Zhizhuang Joe Zhao
Journal:  J Biol Chem       Date:  2006-06-08       Impact factor: 5.157

Review 4.  The role of Src homology 2 containing protein tyrosine phosphatase 2 in vascular smooth muscle cell migration and proliferation.

Authors:  Machender R Kandadi; Matthew S Stratton; Jun Ren
Journal:  Acta Pharmacol Sin       Date:  2010-09-27       Impact factor: 6.150

5.  Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo.

Authors:  Ute Schaeper; Regina Vogel; Jolanta Chmielowiec; Joerg Huelsken; Marta Rosario; Walter Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

Review 6.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

7.  Frs2α and Shp2 signal independently of Gab to mediate FGF signaling in lens development.

Authors:  Hongge Li; Chenqi Tao; Zhigang Cai; Kristina Hertzler-Schaefer; Tamica N Collins; Fen Wang; Gen-Sheng Feng; Noriko Gotoh; Xin Zhang
Journal:  J Cell Sci       Date:  2013-11-27       Impact factor: 5.285

8.  Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking.

Authors:  Klaus Hellmuth; Stefanie Grosskopf; Ching Tung Lum; Martin Würtele; Nadine Röder; Jens Peter von Kries; Marta Rosario; Jörg Rademann; Walter Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205

9.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

10.  A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells.

Authors:  Lisa Salazar; Tamara Kashiwada; Pavel Krejci; Paul Muchowski; Daniel Donoghue; William R Wilcox; Leslie Michels Thompson
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.